Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,376,794 papers from all fields of science
Search
Sign In
Create Free Account
17q25.1
A chromosome band present on 17q
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
17q
Chromosomes
HN1 wt Allele
SRSF2 wt Allele
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Exome array analysis identifies CAV1/CAV2 as a susceptibility locus for intraocular pressure.
Fei Chen
,
A. Klein
,
+5 authors
P. Duggal
Investigative Ophthalmology and Visual Science
2014
Corpus ID: 24747196
PURPOSE Intraocular pressure (IOP) is an important clinical parameter in the evaluation of ocular health. Elevated IOP is a major…
Expand
2011
2011
Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms
K. Rice
,
X. Lin
,
+12 authors
W. Zhang
Blood Cancer Journal
2011
Corpus ID: 18928032
Polycythemia vera (PV), essential thrombocythemia and primary myelofibrosis, are myeloproliferative neoplasms (MPNs) with…
Expand
Review
2008
Review
2008
GRB2 (Growth factor receptor-bound protein 2)
G. Athauda
,
D. Bottaro
2008
Corpus ID: 55226653
Review on GRB2 (Growth factor receptor-bound protein 2), with data on DNA, on the protein encoded, and where the gene is…
Expand
Highly Cited
2006
Highly Cited
2006
Characterisation and differential expression of two very closely related G-protein-coupled receptors, GPR139 and GPR142, in mouse tissue and during mouse development
U. Süsens
,
I. Hermans-Borgmeyer
,
J. Urny
,
H. Schaller
Neuropharmacology
2006
Corpus ID: 21778415
2005
2005
Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1‐q25.2
N. Presneau
,
K. Dewar
,
Vincenzo Forgetta
,
D. Provencher
,
A. Mes-Masson
,
P. Tonin
Molecular Carcinogenesis
2005
Corpus ID: 20855658
Loss of heterozygosity (LOH) analysis was performed in epithelial ovarian cancers (EOC) to further characterize a previously…
Expand
Highly Cited
2005
Highly Cited
2005
Linkage analysis of anorexia and bulimia nervosa cohorts using selected behavioral phenotypes as quantitative traits or covariates
S. Bacanu
,
C. Bulik
,
+15 authors
B. Devlin
American Journal of Medical Genetics Part B…
2005
Corpus ID: 3020013
To increase the likelihood of finding genetic variation conferring liability to eating disorders, we measured over 100 attributes…
Expand
2001
2001
Identification of DMC1, a novel gene in the TOC region on 17q25.1 that shows loss of expression in multiple human cancers
H. Harada
,
H. Nagai
,
M. Tsuneizumi
,
I. Mikami
,
S. Sugano
,
M. Emi
Journal of Human Genetics
2001
Corpus ID: 25570012
AbstractFrequent allelic losses within chromosomal band 17q25.1 in a variety of human cancers have suggested the presence of one…
Expand
2001
2001
Identification, tissue expression, and chromosomal position of a novel gene encoding human ubiquitin-conjugating enzyme E2-230k.
T. Yokota
,
H. Nagai
,
+6 authors
M. Emi
Gene
2001
Corpus ID: 5810602
1999
1999
Frequent allelic loss at the TOC locus on 17q25.1 in primary breast cancers
K. Fukino
,
A. Iida
,
+4 authors
M. Emi
Genes, Chromosomes and Cancer
1999
Corpus ID: 25619102
Sporadic breast cancers often show allelic losses on the long arm of chromosome 17. Since the BRCA1 gene lies at 17q21.1 and the…
Expand
1996
1996
Isolation and mapping of a human gene (SEC14L), partially homologous to yeast SEC14, that contains a variable number of tandem repeats (VNTR) site in its 3' untranslated region.
K. Chinen
,
E. Takahashi
,
Y. Nakamura
Cytogenetics and Cell Genetics
1996
Corpus ID: 3271992
We have isolated a novel human gene, designated SEC14L, that contains tandemly-repeated sequences in the 3' untranslated region…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE